SAN DIEGO, Oct. 18, 2023 /PRNewswire/ -- Inhibrx, Inc. (Nasdaq:INBX), a clinical-stage biopharmaceutical company dedicated to the development of therapeutics for oncology and rare diseases, today announced it will be presenting at the following upcoming scientific conferences:
Read more at prnewswire.comInhibrx Announces Participation in Upcoming Scientific Conferences
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here